Target intelligence / Profile preview

S100 protein family (S100)

Target
S100
Molecular classification
Calcium-binding protein, EF-hand protein, Signaling molecule, Other
01

Overview

The S100 protein family consists of over 20 small, acidic proteins characterized by two EF-hand calcium-binding motifs (UniProt). These proteins function as both intracellular calcium sensors and extracellular signaling molecules, often referred to as damage-associated molecular patterns or DAMPs (PubMed, PMID: 26110551). Intracellularly, they regulate processes such as cell cycle progression, differentiation, and cytoskeleton organization by interacting with various effector proteins in a calcium-dependent manner. Extracellularly, S100 proteins like S100A8, S100A9, and S100B are secreted into the microenvironment where they bind to receptors such as the Receptor for Advanced Glycation End-products (RAGE) and Toll-like receptor 4 (TLR4), triggering pro-inflammatory and pro-survival pathways (PubMed, PMID: 30107173). Due to their overexpression in numerous pathologies, including various cancers, rheumatoid arthritis, and Alzheimer's disease, they are significant therapeutic targets and diagnostic biomarkers (StatPearls). Small molecule inhibitors and neutralizing antibodies are currently being developed to disrupt S100-mediated signaling, particularly in oncology and chronic inflammatory conditions.

Other names
CalgranulinS100 calcium-binding protein familyEF-hand calcium-binding proteinsS100 proteins
02

Mechanism of action

Inhibition of S100-protein interactions, blockade of extracellular S100 binding to receptors like RAGE or TLR4, and modulation of calcium-dependent signaling pathways (PubMed, PMID: 30107173).

03

Biological functions

Calcium signalingCell proliferationCell differentiationApoptosisImmune responseCytoskeleton dynamicsProtein phosphorylation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseAutoimmune disease
05

Safety considerations

Off-target effects due to high structural homology between family membersInterference with essential intracellular calcium homeostasisPotential for systemic immunosuppression when targeting pro-inflammatory members
06

Interacting drugs

Tasquinimod

5 more in the full profile.

07

Biomarkers

S100B (Melanoma, Traumatic brain injury)S100A8/A9 (Calprotectin for Inflammatory bowel disease)S100A12 (Inflammatory diseases)

Beyond the preview

Go deeper on S100 protein family (S100).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S100 protein family (S100).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call